Making Treatment and Screening Decisions for Patients With Prostate Cancer
July 8th 2020Hagen F. Kennecke, MD, MHA, FRCP, medical oncologist, medical director of the Virginia Mason Cancer Institute and current chair of the NCI Rectal-Anal Cancer Task Force, discusses the treatment and screening decision making process for patients with prostate cancer.
Watch
HER2CLIMB Study Shows Efficacy in HER2 Breast Cancer With Brain Metastases
July 1st 2020Nancy U. Lin, MD, discusses the latest findings from the HER2CLIMB study of either tucatinib or placebo, added to trastuzumab and capecitabine, for patients with previously treated HER2-positive metastatic breast cancer who have brain metastases.
Watch